| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0181211508101519 | 0.18751928 |
| NSC 96996 | B 169 | 0.0181211508101519 | 0.18520123 |
| NSC 650365 | Null | 0.0199123109106645 | 0.37133668 |
| NSC 669807 | Null | 0.0199123109106645 | 0.1623755 |
| NSC 756363 | GW804482X | 0.0199123109106645 | 0.10337092 |
| NSC 123528 | Alanine, 3-[(p-methoxy-.alpha.,.alpha.-diphenylbenzyl)thio]-, hydrate [4:1] | 0.0209467683758286 | 0.36773825 |
| NSC 129757 | Null | 0.0209467683758286 | 0.22520023 |
| NSC 132313 | Dianhydrogalactitol | 0.0209467683758286 | 0.28965242 |
| NSC 148790 | Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) | 0.0209467683758286 | 0.17502149 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0209467683758286 | 0.26457952 |